Anxiety and Depression in Women’s Cardiovascular Health: Risk Modifiers, Mechanisms and Clinical Implications

Figures

• 

  Figure 1. Sex-, gender-, and psychosocial determinants of cardiovascular risk in women: an integrated heart–brain–vascular framework. This figure illustrates the multidimensional pathways through which sex-related biological factors, gender-related exposures, psychosocial burden, and behavioral and healthcare mediators interact to shape cardiovascular risk in women. Hormonal transitions, autonomic and neuroendocrine dysregulation, inflammatory activation, endothelial dysfunction, platelet reactivity, caregiving burden, occupational strain, bullying, social inequities, and interpersonal violence may converge with depression, anxiety, chronic stress, rumination, and sleep disturbance to amplify cardiovascular vulnerability. These mechanisms may promote maladaptive health behaviors, impaired adherence, delayed care seeking, cardiometabolic dysfunction, microvascular ischemia, takotsubo syndrome, and adverse atherosclerotic cardiovascular outcomes. The figure emphasizes the need for a sex-informed and bio-psycho-social model of cardiovascular prevention in women and is intended as a conceptual framework that integrates the principal domains discussed in this review, illustrating their…

• 

  Figure 2. The heart–brain–vascular axis linking anxiety to cardiovascular risk in women. The figure illustrates how hormonal transitions across the female lifespan may interact with anxiety-related stress responses, neuroendocrine activation, autonomic dysregulation, and psychosocial burden. These pathways converge on the heart–brain–vascular axis, contributing to impaired cardiovascular regulation, vascular dysfunction, inflammatory activation, microvascular ischemia, arrhythmias, and adverse CV outcomes. The model highlights the multidirectional relationship between psychological health and cardiovascular physiology in women. Abbreviations: BP, blood pressure; CV, cardiovascular; HPA, hypothalamic–pituitary–adrenal; HRV, heart rate variability; PNS, parasympathetic nervous system; SNS, sympathetic nervous system.

• 

  Figure 3. Female-specific life-course windows of affective and cardiovascular vulnerability. This figure summarizes the main female-specific windows during which hormonal transitions, psychosocial stressors, and neuroendocrine changes may amplify vulnerability to anxiety, depression, and cardiovascular dysfunction. Across puberty/adolescence, the premenstrual phase, pregnancy/postpartum, and the menopausal transition, biological and psychosocial determinants interact to influence emotional regulation, autonomic balance, inflammation, endothelial function, and cardiometabolic risk. The scheme highlights these stages as critical opportunities for tailored screening, risk stratification, and integrated preventive interventions. Abbreviation: CV, cardiovascular; HPA, hypothalamic–pituitary–adrenal; PMDD, Premenstrual dysphoric disorder.

• 

  Figure 4. From psychosocial screening to women-centered cardiovascular prevention: a practical life-course clinical pathway. This figure outlines a pragmatic workflow for integrating anxiety and depression assessment into cardiovascular prevention in women across key life-course stages and clinical settings. Women-focused clinical windows include primary prevention, pregnancy and postpartum, perimenopause and menopause, established cardiovascular disease, and conditions characterized by high psychosocial exposure. Screening tools and targeted psychosocial history may help identify depressive symptoms, anxiety, trauma exposure, maladaptive coping, functional impairment, and barriers to adherence. These findings should prompt tailored multidisciplinary actions, including further assessment, safety evaluation, psychological or psychiatric referral when indicated, and implementation of prevention-oriented cardiovascular measures such as optimization of blood pressure, lipids, weight, glycemic control, smoking cessation, physical activity, rehabilitation, and closer longitudinal follow-up. The figure frames psychosocial distress as a clinically actionable cardiovascular risk modifier in women.…